About
Awards
History
Leadership
Board of Directors
Investors and Partners
Pipeline
Cefepime-Taniborbactam
Ceftibuten / VNRX-7145
PBP Inhibitor
VNRX-9945
Publications
Manuscripts
Conference Presentations
News & Events
Press Releases
In the News
Events
Careers
Open Positions
#venatorxcares
Contact
Second Page Test
Publications
MANUSCRIPTS
In Vitro
Activity of Cefepime-Taniborbactam and Comparators against Clinical Isolates of Gram-Negative Bacilli from 2018 to 2020: Results from the Global Evaluation of Antimicrobial Resistance via Surveillance (GEARS) Program
Bronchopulmonary disposition of IV cefepime/taniborbactam (2–0.5 g) administered over 2 h in healthy adult subjects
MORE MANUSCRIPTS
CONFERENCE PRESENTATIONS
In Vitro
Activity of Cefepime-Taniborbactam and Comparators against a Global Collection of Carbapenem-Resistant Enterobacterales (CRE) and Carbapenem-Resistant
Pseudomonas aeruginosa
(CRPA) with and without Carbapenemases
Activities of Cefepime-Taniborbactam and Ceftazidime-Avibactam against Cefepime-Resistant Respiratory Gram-Negative Pathogens in a Hollow Fiber Infection Model
MORE CONFERENCE PRESENTATIONS
You are using a browser that is not supported. Please consider changing your browser
